Vanguard Group’s UROPLASTY INC-NEW UPI Stock Holding History

Vanguard Group’s Portfolio UPI Stock Details UPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-506,090	Closed	-$617K	–	4254
2015 Q1	$617K	Buy	506,090 +3,800	+0.8%	+$5.12K	﹤0.01%	3768
2014 Q4	$1.03M	Buy	502,290 +5,400	+1%	+$12.8K	﹤0.01%	3524
2014 Q3	$1.24M	Buy	496,890 +24,519	+5%	+$64K	﹤0.01%	3446
2014 Q2	$1.27M	Hold	472,371	–	–	﹤0.01%	3423
2014 Q1	$1.72M	Buy	472,371 +33,467	+8%	+$131K	﹤0.01%	3289
2013 Q4	$1.2M	Hold	438,904	–	–	﹤0.01%	3365
2013 Q3	$1.45M	Hold	438,904	–	–	﹤0.01%	3261
2013 Q2	$909K	Buy	+438,904	New	+$1.01M	﹤0.01%	3333

Vanguard Group's UPI Position: Q2 2015 in Review

Vanguard Group sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 506,090 shares — an estimated $617K sold.

Vanguard Group first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $1.72M in Q1 2014. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

Vanguard Group reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
Vanguard Group sold 506,090 UROPLASTY INC-NEW shares in Q2 2015, an estimated $617K.
Vanguard Group first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
Vanguard Group's UROPLASTY INC-NEW position peaked at $1.72M in Q1 2014.
0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.